Orion Corporation: Managers’ transactions – Eija Ronkainen

Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a hundred years of experience in developing, manufacturing, and marketing human and veterinary pharmaceuticals and active pharmaceutical ingredients [2] - The company has a diverse portfolio that includes proprietary and generic medicines as well as consumer health products, focusing on oncology and pain as core therapy areas in its pharmaceutical R&D [2] - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] Managerial Transactions - Eija Ronkainen, a member of the Board and Deputy member, made an initial notification regarding a transaction involving shares of Orion Corporation [1] - The transaction occurred on April 30, 2025, involving the receipt of a share-based incentive, with a volume of 415 shares at a unit price of 0 EUR [1] - The aggregated transaction also reported a volume of 415 shares with a volume-weighted average price of 0 EUR [1]